MedDataX Logo

Clinical Trials

Showing trials with last updates posted in 2017.

NCT03370315 | COMPLETED | NA
20 Participants

Effects of a Dance and Walking Program for People With Parkinson's Disease

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2017-07-01
Completion: 2017-07-01
Conditions
Parkinson Disease
Interventions
OTHER
No Results Yet
NCT03359603 | UNKNOWN | NA
60 Participants

Electro-acupuncture in Knee Osteoarthritis

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2017-12-25
Completion: 2018-04-30
Conditions
Knee Osteoarthritis
Interventions
DEVICE
No Results Yet
NCT03312777 | COMPLETED | PHASE1
60 Participants

Omnitram Pharmacokinetic and Analgesic Study Following CY2D6 Inhibition With Paroxetine In Healthy Volunteers

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2017-10-31
Completion: 2017-12-15
Conditions
Pain
Interventions
DRUG
No Results Yet
NCT03281070 | UNKNOWN
3000 Participants

Anastomotic Leakage After Anterior Resection of Rectal Cancer

Study Type: OBSERVATIONAL
Last Updated: 2017-12-28
Start Date: 2017-10-01
Completion: 2018-05-01
Conditions
Rectal Cancer
No Results Yet
NCT03147469 | COMPLETED | NA
40 Participants

The Influence of Head and Neck Position on Performance of Ambu AuraGain™

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2017-05-17
Completion: 2017-07-05
Conditions
General Anesthesia
Interventions
PROCEDURE
No Results Yet
NCT03137927 | COMPLETED | PHASE1
36 Participants

A Phase I Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2017-06-13
Completion: 2017-12-19
Conditions
Whooping Cough
Interventions
BIOLOGICAL OTHER
No Results Yet
NCT03015714 | COMPLETED | NA
30 Participants

Aquatic Therapy for Freezing of Gait in Parkinson's Disease Patients

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2017-01-31
Completion: 2017-06-30
Conditions
Parkinson Disease Gait Disorders, Neurologic Gait Disorder, Sensorimotor
Interventions
OTHER
No Results Yet
NCT02966457 | COMPLETED | PHASE4
62 Participants

A Study of DEcolonization in Patients With HAematological Malignancies (DEHAM)

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2017-01-31
Completion: 2017-12-31
Conditions
Hematological Infection
Interventions
DRUG
No Results Yet
NCT02795611 | COMPLETED | NA
23 Participants

Family Centered Occupational Therapy on Play Skills and Participation of Children With ASD

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2016-05-31
Completion: 2017-12-31
Conditions
Autism Spectrum Disorder
Interventions
BEHAVIORAL OTHER
No Results Yet
NCT02514772 | COMPLETED | PHASE3
107 Participants

GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera®

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2015-07-31
Completion: 2016-07-31
Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL
Results Available
NCT02483806 | COMPLETED | NA
36 Participants

Effects of Positive End-Expiratory Pressure on Biventricular Function During One-Lung Ventilation

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2015-06-29
Completion: 2016-05-25
Conditions
Lung Cancer
Interventions
PROCEDURE
No Results Yet
NCT02401490 | UNKNOWN | PHASE4
128 Participants

Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathy

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2015-04-30
Completion: 2018-03-31
Conditions
Hepatic Encephalopathy Cirrhosis
Interventions
DRUG
No Results Yet
NCT02301169 | COMPLETED | NA
42 Participants

A Study to Investigate the Effects of a New Treatment in Patients With Chronic Pain

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2014-03-31
Completion: 2014-11-30
Conditions
Peripheral Neuropathies
Interventions
BEHAVIORAL DRUG
Results Available
NCT02242344 | COMPLETED | PHASE2
77 Participants

Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2006-04-30
Completion: 2007-09-30
Conditions
Hypertension
Interventions
DRUG
No Results Yet
NCT02242292 | COMPLETED | PHASE2
527 Participants

Study to Evaluate Efficacy and Safety of Oral Doses of Hyoscine Butylbromide for the Treatment of Occasional Abdominal Pain, Cramping, and Discomfort

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2006-04-30
Completion: 2007-01-31
Conditions
Colic
Interventions
DRUG
No Results Yet
NCT02183324 | COMPLETED | PHASE2
72 Participants

BI 1356 BS in Japanese Patients With Type 2 Diabetes Mellitus

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2007-02-28
Completion: 2007-06-30
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG
No Results Yet
NCT02182063 | COMPLETED | PHASE2
81 Participants

A Study With BIBF 1120 in Patients With Hormone Refractory Prostate Cancer

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2005-11-30
Completion: 2007-01-31
Conditions
Prostatic Neoplasms
Interventions
DRUG
No Results Yet
NCT02182050 | COMPLETED | PHASE2
73 Participants

Efficacy and Safety of Oral Treatment With BIBF 1120 ES in Advanced Non-small-cell Lung Cancer

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2005-08-31
Completion: 2007-01-31
Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG
No Results Yet
NCT01464359 | TERMINATED | PHASE2
3 Participants

T-Cell Depleted Double UCB for Refractory AML

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2011-10-31
Completion: 2013-10-31
Conditions
Acute Myelogenous Leukemia Refractory Acute Myelogenous Leukemia
Interventions
DRUG RADIATION BIOLOGICAL
Results Available
NCT01312818 | TERMINATED | PHASE2
2 Participants

Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2011-06-30
Completion: 2013-01-31
Conditions
Acute Lymphoblastic Leukemia
Interventions
DRUG
Results Available
NCT01215981 | TERMINATED | NA
68 Participants

Influenza Vaccine Post Allogeneic Transplant

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2010-09-30
Completion: 2011-06-30
Conditions
Hematopoietic Stem Cell Transplant Hematologic Malignancy
Interventions
BIOLOGICAL
Results Available
NCT01106950 | TERMINATED | PHASE2
15 Participants

Haploidentical Natural Killer Cells to Treat Refractory or Relapsed Acute Myelogenous Leukemia (AML)

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2010-07-31
Completion: 2011-10-31
Conditions
Leukemia, Myelogenous, Acute
Interventions
BIOLOGICAL DRUG PROCEDURE
Results Available
NCT01105650 | COMPLETED | PHASE2
13 Participants

Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2010-07-31
Completion: 2014-04-30
Conditions
Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer Breast Cancer
Interventions
DRUG BIOLOGICAL
Results Available
NCT01056601 | TERMINATED | PHASE2
7 Participants

Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2010-09-30
Completion: 2011-02-28
Conditions
Pancreatic Cancer
Interventions
DRUG
Results Available
NCT01012362 | TERMINATED | PHASE1
31 Participants

Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2009-12-31
Completion: 2013-02-28
Conditions
Breast Cancer Lung Cancer Colon Cancer Pancreatic Cancer Head and Neck Cancer Kidney Cancer Sarcoma Hepatocellular Cancer
Interventions
DRUG
Results Available
NCT00963872 | TERMINATED | PHASE1/PHASE2
31 Participants

Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2010-03-31
Completion: 2012-08-31
Conditions
Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes
Interventions
DRUG RADIATION BIOLOGICAL
Results Available
NCT00903630 | TERMINATED | PHASE1/PHASE2
15 Participants

Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2009-04-30
Completion: 2011-08-31
Conditions
Fallopian Tube Cancer Ovarian Cancer Peritoneal Cavity Cancer
Interventions
DRUG
Results Available
NCT00882206 | TERMINATED | PHASE2
15 Participants

Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic Leukemia

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2009-04-30
Completion: 2013-01-31
Conditions
Leukemia Lymphoma
Interventions
DRUG
Results Available
NCT00871689 | TERMINATED | PHASE2
2 Participants

Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2009-01-31
Completion: 2010-03-31
Conditions
Leukemia
Interventions
BIOLOGICAL DRUG PROCEDURE RADIATION
Results Available
NCT00818649 | TERMINATED | PHASE2
16 Participants

Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2009-01-31
Completion: 2012-05-31
Conditions
Leukemia Myelodysplastic Syndrome
Interventions
DRUG
Results Available
NCT00790296 | TERMINATED | PHASE2
11 Participants

Evaluation of Synthetic Thyrotropin Releasing Hormone (TRH) as a Treatment for Cancer-related Fatigue

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2006-12-31
Completion: 2010-02-28
Conditions
Cancer-related Fatigue
Interventions
DRUG
Results Available
NCT00749957 | COMPLETED | PHASE1/PHASE2
12 Participants

Phase 1/2 Safety and Efficacy Study of AAV-RPE65 Vector to Treat Leber Congenital Amaurosis

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2009-06-17
Completion: 2014-09-23
Conditions
Leber Congenital Amaurosis
Interventions
BIOLOGICAL
Results Available
NCT00726739 | COMPLETED | PHASE2
21 Participants

Aldesleukin With or Without Vaccine Therapy in Treating Patients With Stage IV Melanoma

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2008-06-30
Completion: 2011-06-30
Conditions
Stage IV Melanoma
Interventions
BIOLOGICAL
Results Available
NCT00668564 | TERMINATED | PHASE2
18 Participants

Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2008-03-31
Completion: 2010-02-28
Conditions
Hurler's Syndrome Maroteaux-Lamy Syndrome Sly Syndrome Alpha Mannosidosis Fucosidosis Aspartylglucosaminuria Sphingolipidoses Krabbe Disease Wolman's Disease Niemann-Pick Disease Type B Niemann-Pick Disease, Type C
Interventions
PROCEDURE DRUG
Results Available
NCT00652899 | TERMINATED | PHASE2
14 Participants

Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2008-03-31
Completion: 2009-08-31
Conditions
Fallopian Tube Cancer Ovarian Cancer Peritoneal Cavity Cancer
Interventions
BIOLOGICAL DRUG RADIATION
Results Available
NCT00638820 | TERMINATED | PHASE2
3 Participants

Reduced Intensity AlloTransplant For Osteopetrosis

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2007-09-30
Completion: 2008-05-31
Conditions
Osteopetrosis
Interventions
PROCEDURE DRUG
Results Available
NCT00625729 | TERMINATED | PHASE1/PHASE2
6 Participants

Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2008-01-31
Completion: 2009-12-31
Conditions
Leukemia Lymphoma
Interventions
BIOLOGICAL DRUG
Results Available
NCT00618540 | TERMINATED | PHASE2
1 Participants

Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2007-01-31
Completion: 2013-05-31
Conditions
Histiocytosis, Langerhans-cell
Interventions
BIOLOGICAL DRUG PROCEDURE
Results Available
NCT00617929 | TERMINATED | PHASE2
12 Participants

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2008-01-31
Completion: 2014-10-31
Conditions
Cancer
Interventions
BIOLOGICAL DRUG PROCEDURE
Results Available
NCT00617188 | COMPLETED | PHASE2
26 Participants

Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer

Study Type: INTERVENTIONAL
Last Updated: 2017-12-28
Start Date: 2007-06-30
Completion: 2008-04-30
Conditions
Ovarian Cancer
Interventions
DRUG
Results Available
Previous
Sorted by latest updates
Next
Showing 40 trials per page · Total 30172 trials